Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility of Using NeuraSignal Transcranial Doppler Robot

NCT: NCT06565442 · NOT_YET_RECRUITING

NCT IDNCT06565442
StatusNOT_YET_RECRUITING
Start Date2026-12-15
Completion2027-12-15
SponsorUniversity of Alabama at Birmingham (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑